RMD - ResMed - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RMD is currently covered by 12 analysts with an average price target of $291.04. This is a potential upside of $17.85 (6.53%) from yesterday's end of day stock price of $273.19.

ResMed's activity chart (see below) currently has 106 price targets and 125 ratings on display. The stock rating distribution of RMD is 66.67% BUY, 31.37% HOLD and 1.96% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 71.57% with an average time for these price targets to be met of 172.24 days.

Highest price target for RMD is $290, Lowest price target is $248, average price target is $249.43.

Most recent stock forecast was given by ANTHONY PETRONE from MIZUHO on 16-Jul-2025.

Split History since 2000:

8/31/10 2 for 1

10/3/05 2 for 1

4/3/00 2 for 1

Currently out of the existing stock ratings of RMD, 34 are a BUY (66.67%), 16 are a HOLD (31.37%), 1 are a SELL (1.96%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$270

$-0.14 (-0.05%)

$250

2 months 3 days ago
(16-Jul-2025)

12/12 (100%)

$15.75 (6.19%)

106

Hold

$248

$-22.14 (-8.20%)

$260

4 months 26 days ago
(24-Apr-2025)

3/3 (100%)

$11.9 (5.04%)

70

Buy

$285

$14.86 (5.50%)

$250

4 months 26 days ago
(24-Apr-2025)

6/6 (100%)

$48.9 (20.71%)

42

Buy

$290

$19.86 (7.35%)

$286

4 months 26 days ago
(24-Apr-2025)

18/18 (100%)

$53.9 (22.83%)

353

Hold

7 months 19 days ago
(31-Jan-2025)

11/11 (100%)

$-7.67 (-3.15%)

212

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RMD (ResMed) average time for price targets to be met?

On average it took 172.24 days on average for the stock forecasts to be realized with a an average price target met ratio 71.57

Which analyst has the current highest performing score on RMD (ResMed) with a proven track record?

MATTHEW MISHAN

Which analyst has the most public recommendations on RMD (ResMed)?

Matthew Mishan works at KEYBANK and has 31 price targets and 17 ratings on RMD

Which analyst is the currently most bullish on RMD (ResMed)?

Mike Polark with highest potential upside - $50.08

Which analyst is the currently most reserved on RMD (ResMed)?

Joanne Wuensch with lowest potential downside - -$150.14

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?